~~<i id='FE51B5D61A'><strike id='FE51B5D61A'><tt id='FE51B5D61A'><pre id='FE51B5D61A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：leisure time 2025-09-03 09:21:39 - browse：88

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： What PEPFAR has meant on the ground in Ukraine

focus

Wikipedia

focus

Wikipedia

explore

focus

AdobeWhenJenniferCasewaslivinginLosAngelesinherearly30s,shewashospitalized11times.Shehadbeenbornwith

WSS

Maui wildfire now ranks as the fifth

Maui wildfire now ranks as the fifth

Pharma patents targeted by Biden in move to slash drug prices

Indictment alleges Trump's ex

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Be careful with at

hotspot

fashion

focus

Cancer drug shortages should be causing more outrage

FDA approves world's first CRISPR

Dobbs anniversary: the lost opportunity of abortion as health care

Montana youths win climate lawsuit against state for promoting fossil fuels

Moonlake's readout produced a cash windfall. Risks remain

BMS, looking to build heart drug business, turns to AI for diagnosis

How to save PrEP access — and even expand it

Hospitals are dialing back on venture capital investing

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Wikipedia

Montana youths win climate lawsuit against state for promoting fossil fuels

Pregnancy discrimination could be enabled by AI

Patients' immediate access to test results puts radiologists in a bind

Americans' trust in science, scientist continues decline: Report

BMS, looking to build heart drug business, turns to AI for diagnosis

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

focus

Wikipedia

explore

focus